The HPRA advises healthcare professionals not to retain printed versions of Summary of Product Characteristics (SPC) documents. As these documents are subject to frequent content updates, including changes to safety and dose related information, we recommend that you visit our website as necessary to access the most up-to-date versions. If you have any queries about specific SPCs on our website then please e-mail info@hpra.ie


Brupro 200mg Film-coated tablets



Rowa Pharmaceuticals LimitedPA0074/067/001

Main Information

Trade NameBrupro 200mg Film-coated tablets
Active SubstancesIbuprofen
Dosage FormFilm-coated tablet
Licence HolderRowa Pharmaceuticals Limited
Licence NumberPA0074/067/001

Group Information

ATC CodeM01AE Propionic acid derivatives
M01AE01 ibuprofen

Status

License statusAuthorised
Licence Issued13/03/2015
Legal statusProduct not subject to medical prescription
Supply StatusSupply through pharmacies only
Advertising StatusAdvertising to the general public
Conditions of LicenceProduct is not subject to medical prescription, subject to the following conditions: Max. Dose 400mg Max. Daily dose 1200mg Max. Pack size: 50 (200mg), 25 (400mg)
Marketing StatusMarketed

Documents

Summary of Product CharacteristicsPDF Version
Package LeafletPDF Version
Public Assessment ReportPDF Version
« Back